TR201714725A1 - Beta-2 agoni̇sti̇ ve anti̇koli̇nerji̇k i̇çeren kuru toz formülasyonu - Google Patents
Beta-2 agoni̇sti̇ ve anti̇koli̇nerji̇k i̇çeren kuru toz formülasyonu Download PDFInfo
- Publication number
- TR201714725A1 TR201714725A1 TR2017/14725A TR201714725A TR201714725A1 TR 201714725 A1 TR201714725 A1 TR 201714725A1 TR 2017/14725 A TR2017/14725 A TR 2017/14725A TR 201714725 A TR201714725 A TR 201714725A TR 201714725 A1 TR201714725 A1 TR 201714725A1
- Authority
- TR
- Turkey
- Prior art keywords
- dry powder
- anticolinergic
- agonist
- beta
- powder formulation
- Prior art date
Links
- 229940124748 beta 2 agonist Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 abstract 1
- 229960002848 formoterol Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 abstract 1
- 229940110309 tiotropium Drugs 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, formoterol ve tiotropiumdan oluşan, kuru toz formundaki farmasötik formülasyonlara ilişkindir.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/14725A TR201714725A1 (tr) | 2017-09-30 | 2017-09-30 | Beta-2 agoni̇sti̇ ve anti̇koli̇nerji̇k i̇çeren kuru toz formülasyonu |
TR2017/16235A TR201716235A2 (tr) | 2017-09-30 | 2017-10-20 | Solunum Yolları Hastalıklarının Tedavisi İçin Birden Fazla Etken Madde İçeren Farmasötik Bileşim |
TR2017/16233A TR201716233A2 (tr) | 2017-09-30 | 2017-10-20 | Solunum yolları hastalıklarının tedavisi için birden fazla etken madde içeren farmasötik bileşim. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/14725A TR201714725A1 (tr) | 2017-09-30 | 2017-09-30 | Beta-2 agoni̇sti̇ ve anti̇koli̇nerji̇k i̇çeren kuru toz formülasyonu |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201714725A1 true TR201714725A1 (tr) | 2019-04-22 |
Family
ID=67981805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2017/14725A TR201714725A1 (tr) | 2017-09-30 | 2017-09-30 | Beta-2 agoni̇sti̇ ve anti̇koli̇nerji̇k i̇çeren kuru toz formülasyonu |
Country Status (1)
Country | Link |
---|---|
TR (1) | TR201714725A1 (tr) |
-
2017
- 2017-09-30 TR TR2017/14725A patent/TR201714725A1/tr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120684T1 (el) | Σκευασμα ξηρης σκονης που περιλαμβανει ενα κορτικοστεροειδες και ενα βητα-αδρενεργικο για χορηγηση δια εισπνοης | |
MA41496A (fr) | Compositions pharmaceutiques comprenant la n-(3,5-diméthoxyphényl)-n'-(1-méthyléthyl)-n-[3-(1-méthyl-1h-pyrazol-4-yl)quinoxalin-6-yl]éthane-1,2-diamine | |
BR112016000489A2 (pt) | composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos | |
MY176176A (en) | Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation | |
CY1124490T1 (el) | Μια διεργασια για την παρασκευη ενος σκευασματος ξηρης σκονης που περιλαμβανει ενα αντιχολινεργικο, ενα κορτικοστεροειδες και ενα βητα-αδρενεργικο | |
CO2019008103A2 (es) | Composiciones farmacéuticas para terapia de combinación | |
IN2013MU03583A (tr) | ||
CL2017000394A1 (es) | Composición que contiene cineol para la administración nasal | |
TR201000681A2 (tr) | İnhalasyon yoluyla alınan kuru toz formülasyonları. | |
MX2015015132A (es) | Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen. | |
MX2015009891A (es) | Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion. | |
BR112019001134A2 (pt) | uso de lactama e composição farmacêutica | |
PH12018502139A1 (en) | Phosphaplatin liquid formulations | |
TR201714725A1 (tr) | Beta-2 agoni̇sti̇ ve anti̇koli̇nerji̇k i̇çeren kuru toz formülasyonu | |
IT201700025738A1 (it) | Composizione farmaceutica comprendente resveratrolo e polimixine per uso come agente antibatterico | |
TR201714728A1 (tr) | Beta-2 Agonist ve Kortikosteroid içeren kuru toz formülasyonu. | |
MX345263B (es) | Formulación de pexiganan estable. | |
TR201714893A1 (tr) | Beta-2 Agonisti ve Kortikosteroid içeren kuru toz bileşimi. | |
TR201716207A2 (tr) | Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar. | |
TR201716155A1 (tr) | Bir beta-2 agonisti ile birlikte bir kortikosteroid içeren farmasötik formülasyon. | |
EP3210614A4 (en) | Composition containing thymosin beta 4, and pharmaceutical formulation comprising same | |
PH12015502029A1 (en) | Phenylephrine resinate particles and use thereof in pharmaceutical formulations | |
SG11201507651XA (en) | Fine dry particulate resveratrol active agent compositions and topical formulations including the same | |
TR201716201A2 (tr) | Beta-2 agonisti içeren kuru toz formülasyonu. | |
TR200907915A2 (tr) | Kuru toz formunda farmasötik bileşim. |